Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Issued: 2022-2025

Historic Shares Issued for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $808,000.

  • Praxis Precision Medicines' Shares Issued rose 301.99% to $808,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 375.29%. This contributed to the annual value of $2.6 million for FY2024, which is 532.93% up from last year.
  • Per Praxis Precision Medicines' latest filing, its Shares Issued stood at $808,000 for Q3 2025, which was up 174.83% from $294,000 recorded in Q2 2025.
  • Praxis Precision Medicines' Shares Issued's 5-year high stood at $2.0 million during Q4 2024, with a 5-year trough of $1,000 in Q3 2023.
  • Its 3-year average for Shares Issued is $428,273, with a median of $208,000 in 2023.
  • In the last 5 years, Praxis Precision Medicines' Shares Issued plummeted by 99.76% in 2023 and then soared by 20,000.00% in 2024.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Shares Issued stood at $163,000 in 2022, then crashed by 34.97% to $106,000 in 2023, then soared by 1,762.26% to $2.0 million in 2024, then skyrocketed by 301.99% to $808,000 in 2025.
  • Its last three reported values are $808,000 in Q3 2025, $294,000 for Q2 2025, and $560,000 during Q1 2025.